LOS sialylation is an important component of gonococcal pathogenesis; isogenic mutants that cannot sialylate their LOS are at a disadvantage in vivo compared to their wild-type counterparts . Manipulation of gonococcal LOS ‘sialylation’ could represent a novel preventive or treatment strategy.